Flutter's FanDuel Full House
This collection features carefully selected stocks across the online gambling ecosystem, handpicked by professional analysts. As Flutter completes its FanDuel acquisition, these companies are positioned to benefit from the booming US sports betting market that's reshaping how Americans engage with sports and entertainment.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
DraftKings
DKNG
Current price
$45.02
As FanDuel's primary competitor, DraftKings benefits from the overall market growth, heightened investor interest, and industry validation this major ...
As FanDuel's primary competitor, DraftKings benefits from the overall market growth, heightened investor interest, and industry validation this major acquisition brings.
MGM Resorts International
MGM
Current price
$36.71
A major casino operator with a strong online presence through BetMGM, benefiting from the expanding digital gaming landscape and industry consolidatio...
A major casino operator with a strong online presence through BetMGM, benefiting from the expanding digital gaming landscape and industry consolidation.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Flutter's complete acquisition of FanDuel signals a major turning point in the US online gambling market. We've assembled a diverse group of companies across the entire sports betting value chain, from direct operators to technology providers and marketing firms, all positioned to capitalize on this high-growth industry as it matures.
What You Need to Know
This collection offers broad exposure to the online betting ecosystem during a period of consolidation and expansion. These companies are riding strong growth tailwinds as more states legalize online gambling and operators invest heavily to acquire customers and secure market share in this competitive landscape.
Why These Stocks
We've selected key players directly involved in the Flutter-FanDuel deal, their primary competitors, and essential ancillary businesses that support the industry. This balanced approach gives you exposure to market leaders while also including specialized technology providers and marketing companies benefiting from increased industry spending.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+31.95%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 31.95% over the next year.
Stocks Rated Buy by Analysts
10 of 11 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
The Betting Boom Is Just Beginning
As more states legalize online gambling and sports betting, these companies are positioned at the starting line of a massive market expansion. With only about half of U.S. states currently allowing online sports betting, there's enormous growth runway ahead.
Consolidation Creates Winners
Flutter's move to take full ownership of FanDuel signals a new phase of industry maturation where the strongest players are consolidating power. This creates opportunities not just for market leaders but for the entire ecosystem of suppliers and partners.
Following The Smart Money
When a major industry player invests billions to secure full ownership at a $31 billion valuation, they're signaling strong confidence in future prospects. This collection lets you align with that same strategic vision across multiple companies in the space.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.